| For: | D'souza S, Lau KCK, Coffin CS, Patel TR. Molecular mechanisms of viral hepatitis induced hepatocellular carcinoma. World J Gastroenterol 2020; 26(38): 5759-5783 [PMID: 33132633 DOI: 10.3748/wjg.v26.i38.5759] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v26/i38/5759.htm |
| Number | Citing Articles |
| 1 |
Zhenyi Lv, Wenqi Gao, Zhiwei Du, Yi Zheng, Tianming Liu, Chenjun Hao, Dongbo Xue. Alternative splicing of IRF3 plays an important role in the development of hepatocarcinoma. Epigenetics 2023; 18(1) doi: 10.1080/15592294.2023.2276371
|
| 2 |
Zijie Wu, Zehua Dong, Jiangti Luo, Weiwei Hu, Yue Tong, Xiangdong Gao, Wenbing Yao, Hong Tian, Xiaosheng Wang. A comprehensive comparison of molecular and phenotypic profiles between hepatitis B virus (HBV)-infected and non-HBV-infected hepatocellular carcinoma by multi-omics analysis. Genomics 2024; 116(3) doi: 10.1016/j.ygeno.2024.110831
|
| 3 |
Kurt Sartorius, Yanglong Wang, Benn Sartorius, Samuel O. Antwi, Xiaodong Li, Anil Chuturgoon, Chongyuan Yu, Yunjie Lu, Yu Wang. The interactive role of microRNA and other non-coding RNA in hepatitis B (HBV) associated fibrogenesis. Functional & Integrative Genomics 2025; 25(1) doi: 10.1007/s10142-024-01519-4
|
| 4 |
Junrui Tian, Jian Ma. The Value of Microbes in Cancer Neoantigen Immunotherapy. Pharmaceutics 2023; 15(8) doi: 10.3390/pharmaceutics15082138
|
| 5 |
Thi Tra Bui, Eunjung Park, Hee‐Yeon Kang, Jin‐Kyoung Oh. Combined effects of smoking and alcohol consumption on the risk of liver cancer according to metabolic syndrome: A nested case–control study in South Korea. International Journal of Cancer 2024; 155(4) doi: 10.1002/ijc.34935
|
| 6 |
Shahab Mahmoudvand, Somayeh Shokri, Mohsen Nakhaie, Farid Azizi Jalilian, Ameneh Mehri-Ghahfarrokhi, Reza Yarani, Ali Shojaeian. Small extracellular vesicles as key players in cancer development caused by human oncogenic viruses. Infectious Agents and Cancer 2022; 17(1) doi: 10.1186/s13027-022-00471-x
|
| 7 |
Gemechu Ameya, Dagim Jirata Birri. The molecular mechanisms of virus-induced human cancers. Microbial Pathogenesis 2023; 183 doi: 10.1016/j.micpath.2023.106292
|
| 8 |
Chen Shen, Xin Jiang, Mei Li, Yao Luo. Hepatitis Virus and Hepatocellular Carcinoma: Recent Advances. Cancers 2023; 15(2) doi: 10.3390/cancers15020533
|
| 9 |
Xin Wu, Xin Zhang, Xiaopeng Yu, Hongyuan Liang, Shaoshan Tang, Yao Wang. Exploring the association between air pollution and the incidence of liver cancers. Ecotoxicology and Environmental Safety 2025; 290 doi: 10.1016/j.ecoenv.2024.117437
|
| 10 |
Chen Zong, Yan Meng, Fei Ye, Xue Yang, Rong Li, Jinghua Jiang, Qiudong Zhao, Lu Gao, Zhipeng Han, Lixin Wei. AIF1+CSF1R+ MSCs, induced by TNF‐α, act to generate an inflammatory microenvironment and promote hepatocarcinogenesis. Hepatology 2023; 78(2) doi: 10.1002/hep.32738
|
| 11 |
Yanxu Li, Hao Zou, Zekun Zheng, Zhuoheng Liu, Huiyuan Hu, Wei Wu, Tao Wang. Advances in the Study of Bioactive Nanoparticles for the Treatment of HCC and Its Postoperative Residual Cancer. International Journal of Nanomedicine 2023; doi: 10.2147/IJN.S399146
|
| 12 |
Devis Pascut, Minh Hoang, Nhu N. Q. Nguyen, Muhammad Yogi Pratama, Claudio Tiribelli. HCV Proteins Modulate the Host Cell miRNA Expression Contributing to Hepatitis C Pathogenesis and Hepatocellular Carcinoma Development. Cancers 2021; 13(10) doi: 10.3390/cancers13102485
|
| 13 |
Elias Kouroumalis, Ioannis Tsomidis, Argyro Voumvouraki. Pathogenesis of Hepatocellular Carcinoma: The Interplay of Apoptosis and Autophagy. Biomedicines 2023; 11(4) doi: 10.3390/biomedicines11041166
|
| 14 |
Mohsen Amirnorouzi, Ahmadmoeen Karimi, Naser Ebrahimi Daryani, Amiratabak Rajaei, Mehrdad Hashemi, Masoud Alebouyeh. Negative feedback loop in the activation of non-homologous end joining DNA repair pathway in Helicobacter pylori infected patients with gastritis. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-74138-5
|
| 15 |
Yanning Li. Virus vaccines in cancer immunotherapy: Principles, and Clinical manifestations. Highlights in Science, Engineering and Technology 2022; 14 doi: 10.54097/hset.v14i.1843
|
| 16 |
Ali Hanbashi, Awaji Y. Safhi, Abdulmajeed Jali, Hamad Alshahi, Obadah E.A. Yousif, Fahad Y. Sabei, Israr Fatima. Exploring apoptotic pathways: implications for cancer, inflammation, and neurodegeneration. Molecular Biology Reports 2026; 53(1) doi: 10.1007/s11033-026-11577-5
|
| 17 |
Qu Xie, Zeyin Zhao, Yanzhen Yang, Dan Long, Cong Luo. Radiomics-guided prognostic assessment of early-stage hepatocellular carcinoma recurrence post-radical resection. Journal of Cancer Research and Clinical Oncology 2023; 149(16) doi: 10.1007/s00432-023-05291-z
|
| 18 |
Maowen Yu, Chaozhu Zhang, Hongbo Tang, Chaohui Xiao, Hangjun Che. Correlation between Serum Oxidative Stress Level and Serum Uric Acid and Prognosis in Patients with Hepatitis B-Related Liver Cancer before Operation. Journal of Healthcare Engineering 2022; 2022 doi: 10.1155/2022/1964866
|
| 19 |
Hang Wang, Bobin Hu, Hengkai Liang, Rongming Wang, Lu Wei, Tumei Su, Qingmei Li, Qianbing Yin, Yanfei Feng, Minghua Su, Jianning Jiang. Impact of HBV Integration on Hepatocellular Carcinoma After Long-Term Antiviral Therapy. International Journal of General Medicine 2024; doi: 10.2147/IJGM.S462844
|
| 20 |
Yingxu Fang, Zehui Lei, Lingqiang Zhang, Cui Hua Liu, Qiyao Chai. Regulatory functions and mechanisms of human microbiota in infectious diseases. hLife 2024; 2(10) doi: 10.1016/j.hlife.2024.03.004
|
| 21 |
Hai He, Jingli Zhu, Qisheng Shen, Zhenghu Feng, Zhiqiang Li, Liping Xu, Tianzhu Song. Subgingival microbial community structure in HCC patients with periodontitis: 16S rRNA sequencing, functional prediction, and phenotypic profiling. European Journal of Medical Research 2026; 31(1) doi: 10.1186/s40001-026-04063-y
|
| 22 |
Chenfang Zhang, Dan Zhang, Xin Wen, Shui Liu. Drug resistance mechanisms of immunotherapy and translational strategies for reversing resistance for hepatocellular carcinoma: from bench to bedside. Frontiers in Immunology 2026; 17 doi: 10.3389/fimmu.2026.1808109
|
| 23 |
Po-Shuan Huang, Ling-Yu Wang, Yi-Wen Wang, Ming-Ming Tsai, Tzu-Kang Lin, Chia-Jung Liao, Chau-Ting Yeh, Kwang-Huei Lin. Evaluation and Application of Drug Resistance by Biomarkers in the Clinical Treatment of Liver Cancer. Cells 2023; 12(6) doi: 10.3390/cells12060869
|
| 24 |
Yung-Tsung Li, Hui-Lin Wu, Chun-Jen Liu. Molecular Mechanisms and Animal Models of HBV-Related Hepatocellular Carcinoma: With Emphasis on Metastatic Tumor Antigen 1. International Journal of Molecular Sciences 2021; 22(17) doi: 10.3390/ijms22179380
|
| 25 |
Sha Li, Wen Liu, Tong‐Tong Wang, Tong‐Qiang Chen, Jin‐Cai Guo. Identification of peanut skin components for treating hepatocellular carcinoma via network pharmacology and in vitro experiments. Chemical Biology & Drug Design 2024; 103(1) doi: 10.1111/cbdd.14428
|
| 26 |
Ilaria Martelli, Lucia Annamaria Cappabianca, Paola Cipriani, Antonietta Rosella Farina, Maddalena Sbaffone, Andrew Reay Mackay. Alternative Splicing in Human Viral Oncogenesis and Tumor Progression. Cancers 2026; 18(12) doi: 10.3390/cancers18122004
|
| 27 |
An Tu, Xiaoning Zhu, Paniz Zarghami Dastjerdi, Yue Yin, Mengyun Peng, Ding Zheng, Zhaoxuan Peng, Encheng Wang, Xiaodong Wang, Wang Jing. Evaluate the clinical efficacy of traditional Chinese Medicine as the neoadjuvant treatment in reducing the incidence of hepatocellular carcinoma in patients with hepatitis B-related cirrhosis: A systematic review and meta-analysis. Heliyon 2024; 10(3) doi: 10.1016/j.heliyon.2024.e24437
|
| 28 |
Linlin Jiang, Qin Meng, Lixiu Liu, Weihang Li. A Comprehensive Review on Molecular Mechanisms, Treatments, and Brief Role of Natural Products in Hepatocellular Cancer. Natural Product Communications 2024; 19(9) doi: 10.1177/1934578X241284873
|
| 29 |
Loraine Kay D. Cabral, Luca Grisetti, Muhammad Yogi Pratama, Claudio Tiribelli, Devis Pascut. Biomarkers for the Detection and Management of Hepatocellular Carcinoma in Patients Treated with Direct-Acting Antivirals. Cancers 2022; 14(11) doi: 10.3390/cancers14112700
|
| 30 |
|
| 31 |
Keyin Zheng, Aimin Jiang, Zhengrui Li, Li Chen, Kailai Li, Junyi Shen, Hank Z. H. Wong, Quan Cheng, Jian Zhang, Anqi Lin, Peng Luo. Bridging viral hepatitis and liver cancer: Emerging concepts in pathogenesis and therapeutic innovation. Clinical and Translational Discovery 2025; 5(3) doi: 10.1002/ctd2.70063
|
| 32 |
Yi Bai, Juan Xu, Deqiang Li, Xiaoyu Zhang, Dapeng Chen, Fucun Xie, Longmei Huang, Xiaotian Yu, Haitao Zhao, Yamin Zhang. HepaClear, a blood-based panel combining novel methylated CpG sites and protein markers, for the detection of early-stage hepatocellular carcinoma. Clinical Epigenetics 2023; 15(1) doi: 10.1186/s13148-023-01508-7
|
| 33 |
Xiaolong Tang, Yandong Miao, Jiangtao Wang, Teng Cai, Lixia Yang, Denghai Mi, Po-Hsiang Tsui. Identification of Mutator-Derived lncRNA Signatures of Genomic Instability for Promoting the Clinical Outcome in Hepatocellular Carcinoma. Computational and Mathematical Methods in Medicine 2021; 2021 doi: 10.1155/2021/1205029
|
| 34 |
Basil Alawyia, Constantina Constantinou. Hepatocellular Carcinoma: a Narrative Review on Current Knowledge and Future Prospects. Current Treatment Options in Oncology 2023; 24(7) doi: 10.1007/s11864-023-01098-9
|
| 35 |
Verena Damiani, Erika Pizzinato, Federica Di Marco, Alessia Lamolinara, Francesco Del Pizzo, Aurora Navicella, Beatrice Dufrusine, Paola Lanuti, Enrico Dainese, Rossano Lattanzio, Manuela Iezzi, Michael Hahne, Damiana Pieragostino, Vincenzo De Laurenzi. Liver‐specific BAG3 knockout delays chemically induced hepatocellular carcinoma development. The FEBS Journal 2026; 293(9) doi: 10.1111/febs.70381
|
| 36 |
Kuldeep Kaur, Justine Beghin, Vanessa Meier-Stephenson. Comparative structural insights of X protein across species and the “lost” BH3-like domain that may explain the absence of hepatocellular carcinoma in birds. Infection, Genetics and Evolution 2025; 132 doi: 10.1016/j.meegid.2025.105777
|
| 37 |
C Wendy Spearman, Geoffrey Dusheiko, Eduard Jonas, Abdelmounem Abdo, Mary Afihene, Lina Cunha, Hailemichael Desalegn, Chris Kassianides, Leolin Katsidzira, Anna Kramvis, Philip Lam, Olufunmilayo A Lesi, Eileen A Micah, Emmanuel Musabeyezu, Gibril Ndow, Chidi V Nnabuchi, Ponsiano Ocama, Edith Okeke, John Rwegasha, Abate B Shewaye, Fatuma F Some, Christian Tzeuton, Mark W Sonderup. Hepatocellular carcinoma: measures to improve the outlook in sub-Saharan Africa. The Lancet Gastroenterology & Hepatology 2022; 7(11) doi: 10.1016/S2468-1253(22)00041-3
|
| 38 |
Wen Jia, Yang Bi. Retinoic acids and nuclear receptor signaling in liver development: Pathogenic roles in liver diseases. Pediatric Discovery 2024; 2(1) doi: 10.1002/pdi3.29
|
| 39 |
Zachary J. Brown, Samantha M. Ruff, Timothy M. Pawlik. The effect of liver disease on hepatic microenvironment and implications for immune therapy. Frontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1225821
|
| 40 |
Rui Huang, Kun Yang, Zejuan Zhang, Lei Song, Kaizhong Dong, Xiaofeng Xie, Xiangjun Hai. Mongolian HCC vs. Caucasian HCC: The Metabolic Reprogramming Process in Mongolian HCC is an Interesting Difference. Biochemical Genetics 2024; 62(3) doi: 10.1007/s10528-023-10527-1
|
| 41 |
Ayma Aftab, Humera Naveed, Habiba Idrees, Liaqat Ali, Muhammad Idrees, Samia Afzal. The emerging role of epigenetics (DNA methylation) in hepatitis C virus-induced hepatocellular carcinoma. Gastrointestinal Tumors 2025; 12(1) doi: 10.48130/git-0025-0007
|
| 42 |
Toofan Datfar, Michael Doulberis, Apostolis Papaefthymiou, Ian N. Hines, Giulia Manzini. Viral Hepatitis and Hepatocellular Carcinoma: State of the Art. Pathogens 2021; 10(11) doi: 10.3390/pathogens10111366
|
| 43 |
Jeffrey V. Lazarus, Camila A. Picchio, Massimo Colombo. Hepatocellular Carcinoma Prevention in the Era of Hepatitis C Elimination. International Journal of Molecular Sciences 2023; 24(18) doi: 10.3390/ijms241814404
|
| 44 |
Orgil Jargalsaikhan, Wenhua Shao, Mayuko Ichimura-Shimizu, Soichiro Ishimaru, Takaaki Koma, Masako Nomaguchi, Battogtokh Chimeddorj, Khongorzul Batchuluun, Ganzorig Batbaatar, Gankhuu Gankhuyag, Saruul Gerelchuluun, Minoru Irahara, Masashi Akaike, Koichi Tsuneyama. Analysis of 69 Hepatocellular Carcinoma Cases from the National Center for Pathology in Mongolia : A Comprehensive Study of Samples Collected Nationwide. The Journal of Medical Investigation 2025; 72(1.2) doi: 10.2152/jmi.72.47
|
| 45 |
Yen-Ju Chen, Chih-Jung Shen, Shao-Hua Yu, Cheng-Li Lin, Hong-Mo Shih. Increased risk of hepatocellular carcinoma in patients with traumatic liver injury. Medicine 2022; 101(6) doi: 10.1097/MD.0000000000028837
|
| 46 |
Ying Liu, Chunhai Hao, Lei Li, Haiguang Zhang, Weina Zha, Longbin Ma, Li Chen, Jianhe Gan. The Role of Oxidative Stress in the Development and Therapeutic Intervention
of Hepatocellular Carcinoma. Current Cancer Drug Targets 2023; 23(10) doi: 10.2174/1568009623666230418121130
|
| 47 |
Wanting Shi, Kang Li, Yonghong Zhang. Current tests for diagnosis of hepatitis B virus infection and immune responses of HBV-related HCC. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1185142
|
| 48 |
Huizhong Shi, Wenwen Zhang, Bingyang Hu, Yafei Wang, Ze Zhang, Ying Sun, Guankun Mao, Chonghui Li, Shichun Lu. Whole-exome sequencing identifies a set of genes as markers of hepatocellular carcinoma early recurrence. Hepatology International 2023; 17(2) doi: 10.1007/s12072-022-10457-x
|
| 49 |
Yusra Zarlashat, Abdul Ghaffar, Flora Guerra, Anna Picca. Immunological Landscape and Molecular Therapeutic Targets of the Tumor Microenvironment in Hepatocellular Carcinoma. International Journal of Molecular Sciences 2025; 26(16) doi: 10.3390/ijms26167836
|
| 50 |
Xuliu Zhou, Yanling Huang, Xueyan Zhang, Wuxiang Guan, Fang Zhang, Haojie Hao. Epitranscriptomic Regulation of Hepatitis B Virus by RNA 5-Methylcytosine: Functions, Mechanisms, and Therapeutic Potential. Viruses 2025; 17(9) doi: 10.3390/v17091159
|
| 51 |
Ryosuke Suzuki, Tetsuro Suzuki. Reverse Genetics of RNA Viruses. Methods in Molecular Biology 2024; 2733 doi: 10.1007/978-1-0716-3533-9_11
|
| 52 |
|
| 53 |
Anna Y. Popova, Yulia V. Ostankova, Alesia Y. Olkhovskaya, Olga A. Petrova, Alexandr N. Shchemelev, Elena N. Serikova, Svetlana A. Egorova, Diana E. Reingardt, Irina V. Drozd, Ojuna B. Zhimbaeva, Ekaterina M. Danilova, Angelica M. Milichkina, Elena B. Ezhlova, Albina A. Melnikova, Natalia S. Bashketova, Lidiya V. Buts, Edward S. Ramsay, Areg A. Totolian. Serological and Molecular Epidemiology of Hepatitis B, C, and D Viruses in Northwest Russia: A Population-Based Cross-Sectional Study. Viruses 2026; 18(6) doi: 10.3390/v18060632
|
| 54 |
James Palmer, Shahrzad Javadi, Stella Yao, Shymaa E. Bilasy, Ahmed El-Shamy. Direct-Acting Antivirals against Hepatitis C. 2026; doi: 10.1016/B978-0-443-41363-6.00011-1
|
| 55 |
Andrea L. Rosenkranz, Kyle C. Yeakle, Michael J. Bouchard. Molecular Medical Microbiology. 2024; doi: 10.1016/B978-0-12-818619-0.00157-X
|
| 56 |
Aref Yarahmadi, Mitra Zare, Masoomeh Aghayari, Hamed Afkhami, Gholam Ali Jafari. Therapeutic bacteria and viruses to combat cancer: double-edged sword in cancer therapy: new insights for future. Cell Communication and Signaling 2024; 22(1) doi: 10.1186/s12964-024-01622-w
|
| 57 |
Mohiniso B. Hidirova, Abrorjon M. Turgunov. A Method for Modeling the Regulation of the Introduction of Genetic Information of the Hepatitis B Virus into the Hepatocyte Genome. 2024 IEEE 25th International Conference of Young Professionals in Electron Devices and Materials (EDM) 2024; doi: 10.1109/EDM61683.2024.10615136
|
| 58 |
Zelin Tian, Chen Xu, Peijun Yang, Zhibin Lin, Wenlong Wu, Wenjie Zhang, Jian Ding, Rui Ding, Xuan Zhang, Kefeng Dou. Molecular pathogenesis: Connections between viral hepatitis-induced and non-alcoholic steatohepatitis-induced hepatocellular carcinoma. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.984728
|
| 59 |
Thomas M. Ruli, Ethan D. Pollack, Atul Lodh, Charles D. Evers, Christopher A. Price, Mohamed Shoreibah. Immune Checkpoint Inhibitors in Hepatocellular Carcinoma and Their Hepatic-Related Side Effects: A Review. Cancers 2024; 16(11) doi: 10.3390/cancers16112042
|
| 60 |
Fatima Fasih, Nusrat Jabeen, Mushtaq Hussain, Atiya Habib, Shaheen Sharafat, Zaheer Ul-Haq. Structural and antigenic variation in Hepatitis B virus oncogene, HBx. Journal of Biomolecular Structure and Dynamics 2026; 44(8) doi: 10.1080/07391102.2025.2517826
|
| 61 |
Furkan Eker, Hatice Duman, Melih Ertürk, Sercan Karav. The potential of lactoferrin as antiviral and immune-modulating agent in viral infectious diseases. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1402135
|
| 62 |
Gulzhanat Nurlanova, Aigerim Iskakova, Akezhan Astrakhanov, Aigul Amanzhanova, Galina Zhumagaliyeva. Polymorphism of the TLR3 gene in Predisposition to Chronic Viral Hepatitis B and C in the population of Turkic-speaking peoples. Research Journal of Pharmacy and Technology 2024; doi: 10.52711/0974-360X.2024.00423
|
| 63 |
Samuel Okoye, Chinedu Obi, Ibrahim Musa. Assessing the Effectiveness of Traditional Chinese Medicine as Neoadjuvant Therapy for Lowering Hepatocellular Carcinoma Risk in Patients with Hepatitis B-Induced Cirrhosis: A Systematic Review and Meta-Analysis. Interdisciplinary Research in Medical Sciences Specialty 2022; 2(2) doi: 10.51847/w6AVDurrhl
|
| 64 |
Edward R. Cachay, Colleen Hadigan, Wm. Christopher Mathews. Clinical guidelines for screening of liver cirrhosis complications remain, and clinical judgement must prevail. AIDS 2021; 35(13) doi: 10.1097/QAD.0000000000003022
|
| 65 |
Kai Zhang, Anna E. Barry, Ryan Lamm, Keyur Patel, Michelle Schafer, Hien Dang. The role of RNA binding proteins in hepatocellular carcinoma. Advanced Drug Delivery Reviews 2022; 182 doi: 10.1016/j.addr.2022.114114
|
| 66 |
. 2023; doi: 10.70675/78863fc0z6809z4b50z97acz3156425d1052
|
| 67 |
Marwa Ahmed Sakr, Khaled Abdel Hamid Mohamed, Ahmed Mohamed Hussein, Mohamed Hassan Fouad, Ahmed Samir Allam, Eslam Safwat. Diagnostic and prognostic value of serum soluble CD163 in cirrhotic patients with hepatitis C virus-related hepatocellular carcinoma before and after locoregional therapy. Egyptian Liver Journal 2021; 11(1) doi: 10.1186/s43066-021-00090-y
|
| 68 |
Juliet A. Shenge, Carla Osiowy. Rapid Diagnostics for Hepatitis B and C Viruses in Low- and Middle-Income Countries. Frontiers in Virology 2021; 1 doi: 10.3389/fviro.2021.742722
|
| 69 |
Snežana Jovanović-Ćupić, Milena Krajnović, Lidija Todorović, Ana Božović, Daniel Galun. HCV-Induced Hepatocarcinogenesis: Molecular Mechanisms, Persistent Cancer Risk, and Future Perspectives. Biomedicines 2026; 14(6) doi: 10.3390/biomedicines14061295
|
| 70 |
Rong Huang, Jinyue Ma, Jiaxin Yao, Jiyu Pang, Min Zhang, Lu Wen, Liang Wang, Yanan Deng, Xiu He, Chunyan Zhao, Bo Mu. Integrated multi-Omics and network toxicology elucidate the multi-target mechanisms of environmental hormones in driving hepatocellular carcinoma. Ecotoxicology and Environmental Safety 2026; 309 doi: 10.1016/j.ecoenv.2025.119519
|
| 71 |
Samiksha Antil, Saravjeet Singh.
Novel La
2
O
3
/g-C
3
N
4
Nanocomposite Electrochemical Immunosensor for Sensitive Detection of Alpha-Fetoprotein in Hepatocellular Carcinoma
. Analytical Letters 2026; 59(15) doi: 10.1080/00032719.2026.2625401
|
| 72 |
Mario Romeo, Marcello Dallio, Flavia Scognamiglio, Lorenzo Ventriglia, Marina Cipullo, Annachiara Coppola, Chiara Tammaro, Giuseppe Scafuro, Patrizia Iodice, Alessandro Federico. Role of Non-Coding RNAs in Hepatocellular Carcinoma Progression: From Classic to Novel Clinicopathogenetic Implications. Cancers 2023; 15(21) doi: 10.3390/cancers15215178
|
| 73 |
Marwa Helal, Marwa Gamal, Ashraf A. Basuni, Walaa El Gendy, Ashraf Khalil. Relative telomer length as a potential biomarker in hepatocellular carcinoma: a comparative study of HCV patients treated with direct antiviral agent. BMC Cancer 2026; 26(1) doi: 10.1186/s12885-025-15339-7
|
| 74 |
Abolfazl Jafari-Sales, Safa Meskini-Marandi, Shabnam Khakpour-Ziaei, Sadra Valipour, Mehrdad Pashazadeh. The hidden yet threatening link between hepatitis B virus and hepatocellular carcinoma: A Narrative Review. Journal of Clinical and Basic Research 2025; 9(2) doi: 10.66224/JCBR.9.2.21
|
| 75 |
Irene Soleto, Alicia C. Marin, Montse Baldan-Martin, David Bernardo, María Chaparro, Javier P. Gisbert. Evaluating the Immunological Impact of Hepatitis B Vaccination in Patients with Inflammatory Bowel Disease. International Journal of Molecular Sciences 2026; 27(1) doi: 10.3390/ijms27010531
|
| 76 |
Jiamin Gao, Zhijian Li, Qinchen Lu, Jialing Zhong, Lixin Pan, Chao Feng, Shaomei Tang, Xi Wang, Yuting Tao, Jianyan Lin, Qiuyan Wang. Single-cell RNA sequencing reveals cell subpopulations in the tumor microenvironment contributing to hepatocellular carcinoma. Frontiers in Cell and Developmental Biology 2023; 11 doi: 10.3389/fcell.2023.1194199
|
| 77 |
Wenze Wu, Fang Lin, Zifan Chen, Kejia Wu, Changhuan Ma, Jing Zhuang, Donglin Sun, Qiang Zhu, Longqing Shi. Identification of hub genes associated with hepatitis B virus-related hepatocellular cancer using weighted gene co-expression network analysis and protein-protein interaction network analysis. Italian Journal of Medicine 2023; 17(2) doi: 10.4081/itjm.2023.1626
|
| 78 |
Evgeniya A. Antropova, Tamara M. Khlebodarova, Pavel S. Demenkov, Anastasiia R. Volianskaia, Artur S. Venzel, Nikita V. Ivanisenko, Alexandr D. Gavrilenko, Timofey V. Ivanisenko, Anna V. Adamovskaya, Polina M. Revva, Nikolay A. Kolchanov, Inna N. Lavrik, Vladimir A. Ivanisenko. Reconstruction of the regulatory hypermethylation network controlling hepatocellular carcinoma development during hepatitis C viral infection. Journal of Integrative Bioinformatics 2024; 20(3) doi: 10.1515/jib-2023-0013
|
| 79 |
Youxi Zhou, Kaizhao Chen, Yang Zhang, Hongwei Cheng, Shuaishuai Zhang. Adoptive cell therapy for HBV-associated liver diseases. Biomedical Technology 2025; 12 doi: 10.1016/j.bmt.2025.100116
|
| 80 |
. 2022; doi: 10.70675/439e8f1azc09cz4c87z9b3fz88c721e1a5b5
|
| 81 |
Yuan Tian, Wenwen Han, Long Fu, Kaiji Lv, Shugeng Wu. CDCA7 serves as a novel prognostic marker in human hepatocellular carcinoma. Biotechnology and Genetic Engineering Reviews 2024; 40(4) doi: 10.1080/02648725.2023.2216072
|
| 82 |
Giovanni Colonna. Effects of SARS-CoV-2 Spike S1 Subunit on the Interplay Between Hepatitis B and Hepatocellular Carcinoma Related Molecular Processes in Human Liver. Livers 2024; 5(1) doi: 10.3390/livers5010001
|
| 83 |
Enhua Shen, Jingzhi Zhang, Yujuan Lu. DEP domain containing 1B (DEPDC1B) exerts the tumor promoter in hepatocellular carcinoma through activating p53 signaling pathway via kinesin family member 23 (KIF23). Bioengineered 2022; 13(1) doi: 10.1080/21655979.2021.2017629
|
| 84 |
Shahrzad Shoraka, Seyed Mahdi Hosseinian, Ayda Hasibi, Amir Ghaemi, Seyed Reza Mohebbi. The role of hepatitis B virus genome variations in HBV-related HCC: effects on host signaling pathways. Frontiers in Microbiology 2023; 14 doi: 10.3389/fmicb.2023.1213145
|
| 85 |
Linjun Liang, Xiaoyan Wang, Shuying Huang, Yanwei Chen, Peng Zhang, Liang Li, Yong Cui. Tyrosine kinase inhibitors as potential sensitizers of adoptive T cell therapy for hepatocellular carcinoma. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1046771
|
| 86 |
Lalita Prasad-Reddy, Amogha Dahal, Andrea J. Zimmer. Vaccinophobia and Vaccine Controversies of the 21st Century. 2026; doi: 10.1007/978-1-0716-5464-4_15
|
| 87 |
Amer Imraish, Walhan Alshaer, Tuqa Abu-Thiab, Fatima Enaya, Hamzeh J. Al‐Ameer, Afnan Alhunaiti, Mohammad Abumurad, Malek Zihlif. siRNA Knocking Down in HepG2 Cells Identifies PFKFB4 and HNF4α as Key Genes Important for Cancer Cell Survival. Current Gene Therapy 2025; 25(5) doi: 10.2174/0115665232337735250101121115
|
| 88 |
Bushra Shihab Hamad Bushra Shihab Hamad, Shahlaa Mahdi Shukr, Alaa Saadi Abbood. Impact of Nanoliposomes on Hepatitis Virus Pathways: A narrative Review. Journal of Medical and Oral Biosciences 2025; doi: 10.58564/jmob.103
|
| 89 |
Samira Dziri, Christophe Rodriguez, Athenaïs Gerber, Ségolène Brichler, Chakib Alloui, Dominique Roulot, Paul Dény, Jean Michel Pawlotsky, Emmanuel Gordien, Frédéric Le Gal. Variable In Vivo Hepatitis D Virus (HDV) RNA Editing Rates According to the HDV Genotype. Viruses 2021; 13(8) doi: 10.3390/v13081572
|
| 90 |
EV Khorkova, LV Lyalina, OM Mikailova, AYu Kovelenov, YuV Ostankova, DE Valutite, TA Stasishkis, VV Tsvetkov, KE Novak, OYu Rishnyak, IV Kritskaya, LV Buts, DS Tyagunov. Current Issues of Epidemiological Surveillance of Chronic Viral Hepatitis B, C, D and Hepatocellular Carcinoma at the Regional Level. ЗДОРОВЬЕ НАСЕЛЕНИЯ И СРЕДА ОБИТАНИЯ - ЗНиСО / PUBLIC HEALTH AND LIFE ENVIRONMENT 2021; doi: 10.35627/2219-5238/2021-29-8-76-84
|
| 91 |
Ricardo Diaz-Aragon, Michael C. Coard, Sriram Amirneni, Lanuza Faccioli, Nils Haep, Michelle R. Malizio, Takashi Motomura, Zehra N. Kocas-Kilicarslan, Alina Ostrowska, Rodrigo M. Florentino, Carla Frau. Therapeutic Potential of HNF4α in End-stage Liver Disease. Organogenesis 2021; 17(3-4) doi: 10.1080/15476278.2021.1994273
|
| 92 |
Shuling Wu, Liu Yang, Xiaoyue Bi, Yanjie Lin, Wen Deng, Tingting Jiang, Minghui Li, Yao Xie. Attach importance to antiviral therapy in patients with hepatocellular carcinoma caused by hepatitis virus. Gastroenterology & Endoscopy 2023; 1(1) doi: 10.1016/j.gande.2022.10.001
|
| 93 |
Lienda Bashier Eltayeb, Deema I Fallatah, Altaf Ali Mangi. Genomic divergence of Hepatitis C virus towards common prescribed interferon regimens on sustained virologic response (SVR) . Journal Of Advanced Pharmacy Education And Research 2022; 12(3) doi: 10.51847/EJ82rOFBiq
|
| 94 |
Lizhi Cao, Xiaoying Wang, Xin Li, Linlin Ma, Yanfei Li. Identification of Co-diagnostic Genes for Heart Failure and Hepatocellular Carcinoma Through WGCNA and Machine Learning Algorithms. Molecular Biotechnology 2024; 66(5) doi: 10.1007/s12033-023-01025-1
|
| 95 |
The oncogenic role of hepatitis B virus X gene in hepatocarcinogenesis: recent updates. Exploration of Targeted Anti-tumor Therapy 2024; 5(1) doi: 10.37349/etat.2024.00209
|
| 96 |
Xingru Zhang, Bangjie Li, Tian Lan, Conner Chiari, Xiaoyang Ye, Kepeng Wang, Ju Chen. The role of interleukin-17 in inflammation-related cancers. Frontiers in Immunology 2025; 15 doi: 10.3389/fimmu.2024.1479505
|
| 97 |
Qing Xiao, Yi Liu, Tingting Li, Chaoyu Wang, Sanxiu He, Liuyue Zhai, Zailin Yang, Xiaomei Zhang, Yongzhong Wu, Yao Liu. Viral oncogenesis in cancer: from mechanisms to therapeutics. Signal Transduction and Targeted Therapy 2025; 10(1) doi: 10.1038/s41392-025-02197-9
|
| 98 |
Wei-Syun Hu, Cheng-Li Lin. Sodium-Glucose Cotransporter-2 Inhibitor versus Beta-Blocker Use for Hepatocellular Carcinoma Risk among People with Hepatitis B or C Virus Infection and Diabetes Mellitus. Cancers 2023; 15(7) doi: 10.3390/cancers15072104
|
| 99 |
Chen Shen, Yi Cao, Guoqiang Qi, Jian Huang, Zhi-Ping Liu. Discovering pathway biomarkers of hepatocellular carcinoma occurrence and development by dynamic network entropy analysis. Gene 2023; 873 doi: 10.1016/j.gene.2023.147467
|
| 100 |
Donlagon Jumparway, Chen-Yang Hsu, Amy Ming-Fang Yen, Ting-Yu Lin, Saman Warnakulasuriya, Tony Hsiu-Hsi Chen, Dih-Ling Luh, Chiu-Wen Su, Pongdech Sarakarn, Yen-Po Yeh, Sam Li-Sheng Chen. Hepatitis C Virus Infection Associated with Oral Potentially Malignant Disorder, Oral Cancer, and Liver Diseases: A Community-Based Cross-Sectional Study. Cancers 2025; 17(22) doi: 10.3390/cancers17223695
|
| 101 |
Qinying Wang, Fanying Guo, Yutao Jin, Yanlei Ma. Applications of human organoids in the personalized treatment for digestive diseases. Signal Transduction and Targeted Therapy 2022; 7(1) doi: 10.1038/s41392-022-01194-6
|
| 102 |
Ahmed Osman Mohamed, Rongzhuo Long, Yin He, Xiaosheng Wang. Comprehensive Analysis of Clinical and Molecular Features in Cancer Patients Associated With Major Human Oncoviruses. Journal of Medical Virology 2025; 97(2) doi: 10.1002/jmv.70239
|
| 103 |
. 2022; doi: 10.70675/77328524zac47z4afdz834cz9e4535aaa50a
|
| 104 |
Yu-Han Yang. Transcatheter arterial chemoembolization plus lenvatinib toward precision prognostication for unresectable hepatocellular carcinoma. World Journal of Gastrointestinal Oncology 2026; 18(6): 116250 doi: 10.4251/wjgo.v18.i6.116250
|
| 105 |
Jadranka Pavicic Saric, Dinka Lulic, Dunja Rogic, Stipislav Jadrijevic, Danko Mikulic, Tajana Filipec Kanizaj, Nikola Prpic, Laura Karla Bozic, Ivona Adamovic, Iva Bacak Kocman, Zrinka Sarec, Gorjana Erceg, Mirta Adanic, Petra Ozegovic Zuljan, Filip Jadrijevic, Ileana Lulic. YKL-40 in Virus-Associated Liver Disease: A Translational Biomarker Linking Fibrosis, Hepatocarcinogenesis, and Liver Transplantation. International Journal of Molecular Sciences 2025; 26(19) doi: 10.3390/ijms26199584
|
| 106 |
Yujian Liu, Jingrui Yang, Rui-Sheng Ke, Lupeng Wu, Zaifa Hong, Ping Guo, Liuxing Feng, Zhimin Li. LINC02875 Upregulation Contributed to Poor Prognosis for the
Hepatocellular Carcinoma and Progression for the Cancerous Cells. Hormone and Metabolic Research 2022; 54(11) doi: 10.1055/a-1913-8223
|
| 107 |
Pin Zhao, Samiullah Malik, Shaojun Xing. Epigenetic Mechanisms Involved in HCV-Induced Hepatocellular Carcinoma (HCC). Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.677926
|
| 108 |
Shivani R Kale, Geeta Karande, Anand Gudur, Aishwarya Garud, Monika S Patil, Satish Patil. Recent Trends in Liver Cancer: Epidemiology, Risk Factors, and Diagnostic Techniques. Cureus 2024; doi: 10.7759/cureus.72239
|
| 109 |
Patricia Martinez-Morales. Pathogens Associated with the Development of Cancer in Humans. 2024; doi: 10.1007/978-3-031-62558-9_22
|
| 110 |
Jin Qian, Ming-Hao Ruan, Zhi-Jie Wang, Wei Dong, Jin-Yong Jia, Xiao-Chen Feng, Hui Liu. Sleep disorders in hepatocellular carcinoma. World Journal of Gastrointestinal Oncology 2025; 17(10): 110503 doi: 10.4251/wjgo.v17.i10.110503
|
| 111 |
Alessio Aghemo, Davide Polverini, Massimo Colombo. Hepatocellular Carcinoma in the Era of Direct Antiviral Agents Against Hepatitis C Virus. Current Hepatology Reports 2024; 23(3) doi: 10.1007/s11901-024-00664-5
|
| 112 |
Jacek Baj, Magdalena Kołodziej, Joanna Kobak, Jacek Januszewski, Kinga Syty, Piero Portincasa, Alicja Forma. Significance of Immune and Non-Immune Cell Stroma as a Microenvironment of Hepatocellular Carcinoma—From Inflammation to Hepatocellular Carcinoma Progression. International Journal of Molecular Sciences 2024; 25(19) doi: 10.3390/ijms251910233
|
| 113 |
Junzhe Liu, Fengze Li, Yulong Cao, Yonghui Lv, Kunjian Lei, Zewei Tu, Chuandong Gong, Haiyan Wang, Feng Liu, Kai Huang. Mechanisms underlining R-loop biology and implications for human disease. Frontiers in Cell and Developmental Biology 2025; 13 doi: 10.3389/fcell.2025.1537731
|
| 114 |
Arshi Khanam, Abutaleb Ameer, Poonam Mathur, Cihan Yurdaydin, Shyam Kottilil. Host Immune Response in Chronic Hepatitis Delta: Implications for Pathogenesis and Therapy. Pathogens 2025; 14(8) doi: 10.3390/pathogens14080828
|
| 115 |
Yanxi Yao, Yifei Zhu, Keji Chen, Jiayu Chen, Yuxue Li, Dawei Li, Ping Wei. Microbiota in cancer: current understandings and future perspectives. Signal Transduction and Targeted Therapy 2026; 11(1) doi: 10.1038/s41392-025-02335-3
|
| 116 |
Chern-Horng Lee, Chien-Heng Shen, Cho-Li Yen, Tzung-Hai Yen, Sen-Yung Hsieh. Discontinuing Hepatitis Activity Reduced Hepatocellular Carcinoma Recurrence after Primary Curative Therapy. Journal of Personalized Medicine 2023; 13(3) doi: 10.3390/jpm13030397
|
| 117 |
Da Gong, Jiaye Mo, Mei Zhai, Fulin Zhou, Guocai Wang, Shaohua Ma, Xiaoyong Dai, Xuesong Deng. Advances, challenges and future applications of liver organoids in experimental regenerative medicine. Frontiers in Medicine 2025; 11 doi: 10.3389/fmed.2024.1521851
|
| 118 |
|
| 119 |
Tina Rahjoo, Alireza Motamedzadeh, Felora Ferdosi, Ehsan Dadgostar, Michael Aschner, Hamed Mirzaei, Sina Ghesmatpour, Fatemeh Nabavizadeh, Fatemeh Rahmati-Dehkordi, Omid Reza Tamtaji. Potential role of thymoquinone to treat gastrointestinal cancers: insights into its molecular mechanisms. Naunyn-Schmiedeberg's Archives of Pharmacology 2025; 398(8) doi: 10.1007/s00210-025-03861-1
|
| 120 |
Yan Li, Sa-Sa Liu, Hua-Rong Jing, Hong-Wei Qian, Rui-Cheng Li. Identifying key genes involved in HBV-related hepatocellular carcinoma: diagnose, prognosis, interaction and immune analysis. Discover Oncology 2025; 16(1) doi: 10.1007/s12672-025-03320-6
|
| 121 |
Tao Zhu, Chunmei Xie, Qianqian Shao, Shuping Zhou, Yong Liang, Xiaolong Tang. PD-L1 upregulated by IGF1R via the PI3K/AKT/NF-κB axis induces sorafenib resistance in hepatocellular carcinoma. Molecular Immunology 2026; 198 doi: 10.1016/j.molimm.2026.08.012
|
| 122 |
Junjie Yin, Mian Wang, Jian Chen, Huigang Li, Jianyong Zhuo, Bei Lu, Yang Cai. CircZCCHC2 (hsa_circ_0000854) promotes hepatocellular carcinoma progression through modulating miR-936/BTBD7 axis and activating Rho/ROCK2 pathway. Non-coding RNA Research 2024; 9(2) doi: 10.1016/j.ncrna.2023.12.004
|
| 123 |
Bao-Kang Wu, Qian-Hui Chen, Dan Pan, Bing Chang, Li-Xuan Sang. A novel therapeutic strategy for hepatocellular carcinoma: Immunomodulatory mechanisms of selenium and/or selenoproteins on a shift towards anti-cancer. International Immunopharmacology 2021; 96 doi: 10.1016/j.intimp.2021.107790
|
| 124 |
Abhilash Perisetti, Hemant Goyal, Rachana Yendala, Ragesh B Thandassery, Emmanouil Giorgakis. Non-cirrhotic hepatocellular carcinoma in chronic viral hepatitis: Current insights and advancements. World Journal of Gastroenterology 2021; 27(24): 3466-3482 doi: 10.3748/wjg.v27.i24.3466
|
| 125 |
Mustafa Ahmed Yousif, Ibrahim Siddig Mohammed, Siddig Osman Mohammed, Maab Elyas Gebreel, Rayan Mohammed Alhaj, Duha Atef Alsier, Hadia Babiker Abdelbasit, Habab Merghani Yassin, Lienda Bashier Eltayeb. Nosocomial Transmission of Hepatitis B Surface Antigen and Anti-Hepatitis C Virus among Hemodialysis Patients. Archives Of Pharmacy Practice 2022; 13(3) doi: 10.51847/LCcAdvtrzs
|
| 126 |
Eirini Karamichali, Pelagia Foka, Georgia Papadopoulou, Domniki Loukaki-Gkountara, Konstantina Andresaki, Ioannis Koskinas, Urania Georgopoulou. Hepatitis Viruses Control Host Immune Responses by Modifying the Exosomal Biogenesis Pathway and Cargo. International Journal of Molecular Sciences 2022; 23(18) doi: 10.3390/ijms231810862
|
| 127 |
Youpeng Wang, Yeni Yang, Ziyin Zhao, Hongfa Sun, Dingan Luo, Lakshmi Huttad, Bingyuan Zhang, Bing Han. A new nomogram model for prognosis of hepatocellular carcinoma based on novel gene signature that regulates cross-talk between immune and tumor cells. BMC Cancer 2022; 22(1) doi: 10.1186/s12885-022-09465-9
|
| 128 |
Raffaele La Porta, Antonio Vitiello, Annalisa Belli, Davide Sisti, Andrea Zovi, Francesca Bruscolini, Saverio Guerra, Sara Carbonari, Sara Di Benedetto, Tania Rodini, Simone Barocci, Stefano Amatori. Evaluation of the hepatitis c virus screening program in the Marche Region (Italy): experience from the Pesaro–Urbino health authority. European Journal of Clinical Microbiology & Infectious Diseases 2026; 45(5) doi: 10.1007/s10096-026-05430-7
|
| 129 |
Theerut Luangmonkong, Pittaya Puphancharoensuk, Varisara Tongsongsang, Peter Olinga, Warisara Parichatikanond. Hepatoprotective Efficacy of Cycloastragenol Alleviated the Progression of Liver Fibrosis in Carbon-Tetrachloride-Treated Mice. Biomedicines 2023; 11(1) doi: 10.3390/biomedicines11010231
|
| 130 |
Ivana Milošević, Nataša Nikolić, Sanja Stanković, Ana Filipović, Jovana Ranin, Irena Paunović, Jelena Simić, Branko Beronja. Pilot Study of PIVKA-II in the Prognostic Assessment of Hepatocellular Carcinoma in Chronic Viral Hepatitis: Comparative Findings from HBV and HCV Cohorts from a Single Center in Serbia. Biomedicines 2025; 13(11) doi: 10.3390/biomedicines13112653
|
| 131 |
Chia-Chen Chen, Guiwen Guan, Xuewei Qi, Abudurexiti Abulaiti, Ting Zhang, Jia Liu, Fengmin Lu, Xiangmei Chen. Pacbio Sequencing of PLC/PRF/5 Cell Line and Clearance of HBV Integration Through CRISPR/Cas-9 System. Frontiers in Molecular Biosciences 2021; 8 doi: 10.3389/fmolb.2021.676957
|
| 132 |
Theerut Luangmonkong, Warisara Parichatikanond, Peter Olinga. Targeting collagen homeostasis for the treatment of liver fibrosis: Opportunities and challenges. Biochemical Pharmacology 2023; 215 doi: 10.1016/j.bcp.2023.115740
|
| 133 |
Dallyla Jennifer Morais de Sousa, Kynnara Gabriella Feitosa de Oliveira, Irislene Costa Pereira, Glauto Tuquarre Melo do Nascimento, Clenio Oliveira Barrense, Jorddam Almondes Martins, Beatriz de Mello Pereira Rêgo, Tiago Eugênio Oliveira da Silva, Felipe Cavalcanti Carneiro da Silva, Francisco Leonardo Torres-Leal. Dietary restriction and hepatic cancer: Systematic review and meta-analysis of animal studies. Critical Reviews in Oncology/Hematology 2024; 196 doi: 10.1016/j.critrevonc.2024.104264
|
| 134 |
Shiyan Shang, Haixia Yang, Linlin Qu, Daidi Fan, Jianjun Deng. Ginsenoside, a potential natural product against liver diseases: a comprehensive review from molecular mechanisms to application. Critical Reviews in Food Science and Nutrition 2025; 65(30) doi: 10.1080/10408398.2025.2451761
|
| 135 |
Hui-Chun Li, Chee-Hing Yang, Shih-Yen Lo. Long noncoding RNAs in hepatitis B virus replication and oncogenesis. World Journal of Gastroenterology 2022; 28(25): 2823-2842 doi: 10.3748/wjg.v28.i25.2823
|
| 136 |
Fabiola Justina Fumero León, Flor Helene Pujol. Intestinal Microbiota and Hepatitis C: Dysbiosis During the Natural History of the Disease and Treatment. Livers 2026; 6(1) doi: 10.3390/livers6010011
|
| 137 |
Yiwen Liu, Fuyou Zhou, Haijun Yang, Zheyuan Zhang, Jiahao Zhang, Keyao He, Mengfan Qian, Ruonan Li, Wei Sun, Ningtao Dai, Junkuo Li, Yibo Guo, Jinyu Kong, Shegan Gao. Porphyromonas gingivalis promotes malignancy and chemo-resistance via GSK3β-mediated mitochondrial oxidative phosphorylation in human esophageal squamous cell carcinoma. Translational Oncology 2023; 32 doi: 10.1016/j.tranon.2023.101656
|
| 138 |
Abubakar Yaro, Svetoslav Martinov, Catherine Johnson. Efficacy of combined antiretroviral therapy (cART) in Hepatitis B and C associated hepatocellular carcinoma (HCC): a narrative review. Journal of Human Virology & Retrovirology 2023; 10(3) doi: 10.15406/jhvrv.2023.10.00271
|
| 139 |
Cynthia H. Chiu. CRISPR/Cas9 genetic screens in hepatocellular carcinoma gene discovery. Current Research in Biotechnology 2023; 5 doi: 10.1016/j.crbiot.2023.100127
|
| 140 |
Lvying Wu, Lingfeng Zhu, Jin Chen. Diverse potential of chimeric antigen receptor‐engineered cell therapy: Beyond cancer. Clinical and Translational Medicine 2025; 15(4) doi: 10.1002/ctm2.70306
|
| 141 |
Mohd Suhail, Sayed Sartaj Sohrab, Mohammad Amjad Kamal, Esam Ibraheem Azhar. Role of hepatitis c virus in hepatocellular carcinoma and neurological disorders: an overview. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.913231
|
| 142 |
Mengfei Sheng, Yuanyuan Zhang, Yaoyun Wang, Weiyi Liu, Xingyu Wang, Tiaoying Ke, Pingyang Liu, Sihan Wang, Wei Shao. Decoding the role of aberrant RNA alternative splicing in hepatocellular carcinoma: a comprehensive review. Journal of Cancer Research and Clinical Oncology 2023; 149(19) doi: 10.1007/s00432-023-05474-8
|
| 143 |
Yani Ke, Yuyan Pan, Xueru Huang, Xing Bai, Xiaojuan Liu, Mingsi Zhang, Tao Jiang, Guangji Zhang. Correlations between circulating adipokines and hepatocellular carcinoma: a Systematic Review and meta-analysis. Frontiers in Endocrinology 2025; 16 doi: 10.3389/fendo.2025.1548924
|
| 144 |
Juris Jansons, Dace Skrastina, Alisa Kurlanda, Stefan Petkov, Darya Avdoshina, Yulia Kuzmenko, Olga Krotova, Olga Trofimova, Ilya Gordeychuk, Irina Sominskaya, Maria Isaguliants. Reciprocal Inhibition of Immunogenic Performance in Mice of Two Potent DNA Immunogens Targeting HCV-Related Liver Cancer. Microorganisms 2021; 9(5) doi: 10.3390/microorganisms9051073
|
| 145 |
Akshatha N. Srinivas, Diwakar Suresh, Savneet Kaur, Divya P. Kumar. The promise of small particles: extracellular vesicles as biomarkers in liver pathology. The Journal of Physiology 2023; 601(22) doi: 10.1113/JP283074
|
| 146 |
Lu-Qi Cao, Yuhao Xie, Joshua S. Fleishman, Xuan Liu, Zhe-Sheng Chen. Hepatocellular carcinoma and lipid metabolism: Novel targets and therapeutic strategies. Cancer Letters 2024; 597 doi: 10.1016/j.canlet.2024.217061
|
| 147 |
N. A. Vlasova, V. I. Apanasevich, E. V. Eliseeva, S. S. Startsev. Etiologic, epidemic, medical and economic aspects of hepatocellular carcinoma. Сибирский научный медицинский журнал 2025; 45(1) doi: 10.18699/SSMJ20250101
|
| 148 |
Sheridan L. Reed, Vishnu M. Chandra, William F. Pritchard, Andrew S. Mikhail, John W. Karanian, Carla S. Coffin, Bradford J. Wood, Luke R. Wilkins. The Woodchuck Hepatitis Virus Model of Hepatocellular Carcinoma for Interventional Radiology Research. Journal of Vascular and Interventional Radiology 2025; 36(12) doi: 10.1016/j.jvir.2025.09.002
|
| 149 |
Kaixuan Xu, Xinxin Wang, Shuwei Hu, Jiaxuan Tang, Shihui Liu, Hui Chen, Xiaobin Zhang, Penggao Dai. LINC00540 promotes sorafenib resistance and functions as a ceRNA for miR-4677-3p to regulate AKR1C2 in hepatocellular carcinoma. Heliyon 2024; 10(5) doi: 10.1016/j.heliyon.2024.e27322
|
| 150 |
Jingjing Zhang, Qingrong Zhang, Wenyan Hu, Yuxuan Liang, Deke Jiang, Haitao Chen. A transcriptome-wide association study identified susceptibility genes for hepatocellular carcinoma in East Asia. Gastroenterology Report 2023; 12 doi: 10.1093/gastro/goae057
|
| 151 |
Yang Li, Jun Shi, Aiqing Zhao, Jing Huang, Lei Dai. Decoding the cholesterol–apoptosis axis in HCC: a machine learning-based multi-omics integration and single-cell transcriptomic analysis. Discover Oncology 2025; 16(1) doi: 10.1007/s12672-025-04010-z
|
| 152 |
Renata Santos de Sousa, Lorena de Carvalho Corrêa, Fabiola Santos da Silva Matos, Samia Meneses dos Santos, Marcos Daniel Mendes Padilha, Carolina Cabral Angelim, Álesson Adam Fonseca Andrade, Amanda Roberta Vieira Sacramento, Aline Cecy Rocha de Lima, João Lukas Nunes Almeida, Mauro Sérgio Moura de Araújo, Vitória Sahena Martins Souza Barbosa, Jacqueline Cortinhas Monteiro, Greice de Lemos Cardoso Costa, Andréa Nazaré Monteiro Rangel da Silva, Simone Regina Souza da Silva Conde, Luiz Fernando Almeida Machado, Izaura Maria Vieira Cayres Vallinoto, Antonio Carlos Rosário Vallinoto, Rosimar Neris Martins Feitosa. Prevalence of Human T-Lymphotropic Viruses 1 and 2 in Individuals Infected with Hepatitis C Virus in Belém do Pará, Brazil. Tropical Medicine and Infectious Disease 2026; 11(4) doi: 10.3390/tropicalmed11040095
|
| 153 |
Iman M. El-Zehery, Mohamed El-Mesery, Mohamed El-Sherbiny, Amal M. El Gayar, Nada H. Eisa. Carbenoxolone upregulates TRAIL\TRAILR2 expression and enhances the anti-neoplastic effect of doxorubicin in experimentally induced hepatocellular carcinoma in rats. Biochemical and Biophysical Research Communications 2024; 741 doi: 10.1016/j.bbrc.2024.150876
|
| 154 |
Kinza Sabir, Jawayria Sajid, Nauman I Butt, Barak Waris, Amal Zahra, Muhammad Shoaib. Clinical Profile and Outcome of Patients With Advanced Hepatocellular Carcinoma (HCC) Taking Sorafenib or Lenvatinib: Real-World Experience From a Low-Middle Resource Country. Cureus 2025; doi: 10.7759/cureus.83681
|
| 155 |
Ana Banko, Danijela Miljanovic, Andja Cirkovic. Systematic review with meta-analysis of active herpesvirus infections in patients with COVID-19: Old players on the new field. International Journal of Infectious Diseases 2023; 130 doi: 10.1016/j.ijid.2023.01.036
|
| 156 |
Mohammad Darvishi, Majid Nouri, Rasoul Rahimi, Saeid Heidari-Soureshjani, Seyed Mahmoud Reza Hashemi Rafsanjani. A Systematic Review of the Impact of Resveratrol on Viral Hepatitis and Chronic Viral Hepatitis-related Hepatocellular Carcinoma. Current Molecular Medicine 2025; 25(5) doi: 10.2174/0115665240284347240125072555
|
| 157 |
Ahmed Gaballah, Birke Bartosch. An Update on the Metabolic Landscape of Oncogenic Viruses. Cancers 2022; 14(23) doi: 10.3390/cancers14235742
|
| 158 |
Guadalupe Hernández-Martínez, Andrés Hernández-Oliveras, Ángel Zarain-Herzberg, Juan Santiago-García, Kieran Campbell. Transcriptional and epigenetic regulation of Ca2+-signaling genes in hepatitis B-derived hepatocellular carcinoma and their association with the cancer hallmarks. Bioinformatics Advances 2026; 6(1) doi: 10.1093/bioadv/vbaf331
|
| 159 |
Bingyan Liang, Jia Tan, Jia Li, Xiaolan Wang, Genlin Li, Huanhuan Li, Ting Li, Hong Gao. Epidemiology, molecular typing, microbiome-immune interactions and treatment strategies of endometrial cancer: a review. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1595638
|
| 160 |
Ema Elvira Herrera-López, Dafne Guerrero-Escalera, Isaac Aguirre-Maldonado, Arely López-Hernández, Hilda Montero, María Angélica Gutiérrez‐Nava, Luis del Pozo-Yauner, Jaime Arellanes-Robledo, Javier Camacho, Julio Isael Pérez-Carreón. Annexins A2 and A5 are potential early biomarkers of hepatocarcinogenesis. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-34117-8
|
| 161 |
Brian M. Fung, James H. Tabibian. Primary sclerosing cholangitis-associated cholangiocarcinoma: special considerations and best practices. Expert Review of Gastroenterology & Hepatology 2021; 15(5) doi: 10.1080/17474124.2021.1900732
|
| 162 |
Association between ascites Gustave Roussy immune score and the intratumoural microbiome in malignant ascites secondary to hepatocellular carcinoma. International Immunopharmacology 2024; 133 doi: 10.1016/j.intimp.2024.112097
|
| 163 |
Ashraf Elbahrawy, Hassan Atalla, Abdulla A. Mahmoud, Ahmed Eliwa, Alaa Alsawak, Mohamed Alboraie, Ali Madian, Ahmed Alashker, Sadek Mostafa, Ahmed Alwassief, Hussein H. Aly. Prediction and surveillance of de novo HCC in patients with compensated advanced chronic liver disease after hepatitis C virus eradication with direct antiviral agents. Frontiers in Virology 2023; 3 doi: 10.3389/fviro.2023.1227317
|
| 164 |
Lampros Chrysavgis, Evangelos Cholongitas. Recent Advances in Liver Cirrhosis Related Complications. 2025; doi: 10.1016/B978-0-443-21938-2.00020-5
|
| 165 |
Vuyolwethu Khwaza, Buhle Buyana, Xhamla Nqoro, Sijongesonke Peter, Zintle Mbese, Zizo Feketshane, Sibusiso Alven, Blessing A. Aderibigbe. Viral Infections and Antiviral Therapies. 2023; doi: 10.1016/B978-0-323-91814-5.00018-0
|
| 166 |
Marianela Giorgio, Kelly Alejandra Ramírez Ladino, Guido López, Maricel Sosa Rojas, Estela Outon, Cecilia María Delfino. Frequency of hepatitis D virus with different hepatitis B virus serological markers and coinfections in hospital patients from Argentina: synchronous testing of anti-HDV antibodies and HDV RNA. European Journal of Gastroenterology & Hepatology 2025; 37(1) doi: 10.1097/MEG.0000000000002857
|
| 167 |
Can Liu, Ru Qiao, Peng He, Wang Chen, Xiangting Gao, Fuyuan He. Mechanistic insights into aristolochic acid-induced hepatocellular carcinoma: a multi-dimensional analysis integrating network toxicology, machine learning, and molecular dynamics simulation. Toxicon 2025; 267 doi: 10.1016/j.toxicon.2025.108576
|
| 168 |
Xia Yin, Fanggong Kan. Hepatitis E virus infection and risk of hepatocellular carcinoma: A systematic review and meta-analysis. Cancer Epidemiology 2023; 87 doi: 10.1016/j.canep.2023.102457
|
| 169 |
Elisabeth Digifico, Silvia Balinzo, Cristina Belgiovine. The Dark Side of the Force: When the Immune System Is the Fuel of Tumor Onset. International Journal of Molecular Sciences 2021; 22(3) doi: 10.3390/ijms22031224
|
| 170 |
Song Gao, Xingyue Jiang, Liang Wang, Shanshan Jiang, Hanyuan Luo, Yan Chen, Cheng Peng. The pathogenesis of liver cancer and the therapeutic potential of bioactive substances. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.1029601
|
| 171 |
Yu Min, Xiaoyuan Wei, Xi Xia, Zhigong Wei, Ruidan Li, Jing Jin, Zheran Liu, Xiaolin Hu, Xingchen Peng. Hepatitis B virus infection: An insight into the clinical connection and molecular interaction between hepatitis B virus and host extrahepatic cancer risk. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1141956
|
| 172 |
Gerardo B. Figueroa, Simmone D'souza, Higor S. Pereira, Gunjan Vasudeva, Sara B. Figueroa, Zachary E. Robinson, Maulik D. Badmalia, Vanessa Meier‐Stephenson, Jennifer A. Corcoran, Guido van Marle, Yi Ni, Stephan Urban, Carla S. Coffin, Trushar R. Patel. Development of a single‐domain antibody to target a G‐quadruplex located on the hepatitis B virus covalently closed circular DNA genome. Journal of Medical Virology 2024; 96(6) doi: 10.1002/jmv.29692
|
| 173 |
Xiaoyu Li, Masahiko Ito, Haruyo Aoyagi, Asako Murayama, Hideki Aizaki, Masayoshi Fukasawa, Takanobu Kato, Takaji Wakita, Tetsuro Suzuki. Development and Use of a Kinetical and Real-Time Monitoring System to Analyze the Replication of Hepatitis C Virus. International Journal of Molecular Sciences 2022; 23(15) doi: 10.3390/ijms23158711
|
| 174 |
Angelo Bruni, Chiara Castellana, Elton Dajti, Giovanni Barbara, Giovanni Marasco, Marcello Maida, Gaetano Serviddio, Antonio Facciorusso. Epidemiological, diagnostic, therapeutic and prognostic impact of hepatitis B and D virus infection on hepatocellular carcinoma: A review of the literature. Virology 2024; 600 doi: 10.1016/j.virol.2024.110273
|
| 175 |
Amanda Jean Craig, Xin Wei Wang. Hepatitis B Virus and Liver Disease. 2021; doi: 10.1007/978-981-16-3615-8_6
|
| 176 |
Giacomo Emanuele Maria Rizzo, Giuseppe Cabibbo, Antonio Craxì. Hepatitis B Virus-Associated Hepatocellular Carcinoma. Viruses 2022; 14(5) doi: 10.3390/v14050986
|
| 177 |
Yu Jiang, Qiuju Han, Huajun Zhao, Jian Zhang. The Mechanisms of HBV-Induced Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma 2021; doi: 10.2147/JHC.S307962
|
| 178 |
Xue Pang, Wei Wan, Xingxing Wu, Yu Shen, Ferenc Olasz. The Novel Action of miR-193b-3p/CDK1 Signaling in HCC Proliferation and Migration: A Study Based on Bioinformatic Analysis and Experimental Investigation. International Journal of Genomics 2022; 2022 doi: 10.1155/2022/8755263
|
| 179 |
Jingyuan Zhang, Zhihong Huang, Xinkui Liu, Chao Wu, Wei Zhou, Peizhi Ye, Antony Stalin, Shan Lu, Yingying Tan, Zhishan Wu, Xiaotian Fan, Xiaomeng Zhang, Miaomiao Wang, Bingbing Li, Guoliang Cheng, Yanfang Mou, Jiarui Wu, Shibiao Wan. Exploring the Multicomponent Synergy Mechanism of Yinzhihuang Granule in Inhibiting Inflammation‐Cancer Transformation of Hepar Based on Integrated Bioinformatics and Network Pharmacology. BioMed Research International 2022; 2022(1) doi: 10.1155/2022/6213865
|
| 180 |
James Lok, Kosh Agarwal. Screening for Hepatocellular Carcinoma in Chronic Hepatitis B: An Update. Viruses 2021; 13(7) doi: 10.3390/v13071333
|
| 181 |
Saleh A. Alqahtani, Massimo Colombo. Treatment for Viral Hepatitis as Secondary Prevention for Hepatocellular Carcinoma. Cells 2021; 10(11) doi: 10.3390/cells10113091
|
| 182 |
Nicole E. Rich, Augusto Villanueva, Jorge A. Marrero, Fasiha Kanwal. AGA Clinical Practice Update on Risk Stratification and Emerging Surveillance Strategies for Hepatocellular Carcinoma: Expert Review. Gastroenterology 2026; 170(7) doi: 10.1053/j.gastro.2026.03.006
|
| 183 |
Bingqian Qu, Firat Nebioglu, Mila M. Leuthold, Yi Ni, Pascal Mutz, Jürgen Beneke, Holger Erfle, Florian W.R. Vondran, Ralf Bartenschlager, Stephan Urban. Dual role of neddylation in transcription of hepatitis B virus RNAs from cccDNA and production of viral surface antigen. JHEP Reports 2022; 4(10) doi: 10.1016/j.jhepr.2022.100551
|
| 184 |
Nana Yao, Bo Huang. Mechanisms of Viral Oncogenesis: DNA and RNA Viruses in Human Cancer. Journal of Inflammation Research 2025; doi: 10.2147/JIR.S529301
|
| 185 |
Yibin Che, Ge Wang, Qiang Xia. CDK2AP1 influences immune infiltrates and serves as a prognostic indicator for hepatocellular carcinoma. Frontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.937310
|
| 186 |
Eman M. F. Barakat, Mohamed Kohla, Ahmed Tawheed, Hend Ibrahim Shousha, Ehab F. Moustafa, Mohamed Said, Hamdy Sayed, Eman Rewisha, Ashraf Omar Abdelaziz, Khaled M. Abd Elaziz, Mohamed Omar Abdelmalek, Hossam Dabees, Amr El Fouly, Eman Elkhateeb, Mohamed Mahmoud Nabeel, Mohamed Eltabbakh, Ahmed Radwan Riad, Anwar Nasif, Nermeen Abdeen, Mostafa Elhelbawy, Tamer Elbaz, Safaa Ragab Askar, Mona Shoukry, Yosra Khalifa, Ahmed Hosni Abdelmaksoud, Mostafa Abd Alfattah Shamkh, Mona Kaddah, Yasser Arafat Abdelrazek, Rania Lithy, Ahmed A. Sleem, Mohamed bassam Hashem, Abdelaziz Ahmed Abdelaziz, Ahmed Ramadan, Hoda M. Farid, Nourhan Mohamed Abdallah, Mohamed Shaker Ghazy, Mohamed ElGharib AbouElmaaty, Mohammed Sobhi Hassan, Mohamed El‐Kassas. Outcomes and Survival of Egyptian Patients With Hepatitis B–Related Hepatocellular Carcinoma: A Multicentre Retrospective Study. Journal of Viral Hepatitis 2026; 33(2) doi: 10.1111/jvh.70127
|
| 187 |
Gulsum Ozlem Elpek. Molecular pathways in viral hepatitis-associated liver carcinogenesis: An update. World Journal of Clinical Cases 2021; 9(19): 4890-4917 doi: 10.12998/wjcc.v9.i19.4890
|
| 188 |
Abolfazl Jafarı-sales, Parniya Nouri-dizaj, Soheyla Hosseyni-nasababad, Sanam Karzar-torkambour, Aylin Golestani, Zahra Ghahremani, Mehrdad Pashazadeh, Sara Naebi. Hepatitis C Virus (HCV) and Hepatitis D Virus (HDV): Divergent Pathways to Hepatocellular Carcinoma (HCC) and Therapeutic Strategies. Archives of Current Medical Research 2026; 7(1) doi: 10.47482/acmr.1714274
|
| 189 |
Mario Capasso, Valentina Cossiga, Maria Guarino, Luisa Ranieri, Filomena Morisco. The Role of Hepatitis Viruses as Drivers of Hepatocancerogenesis. Cancers 2024; 16(8) doi: 10.3390/cancers16081505
|
| 190 |
Pinelopi Samara, Michail Athanasopoulos, Stylianos Mastronikolis, Efthymios Kyrodimos, Ioannis Athanasopoulos, Nicholas S. Mastronikolis. The Role of Oncogenic Viruses in Head and Neck Cancers: Epidemiology, Pathogenesis, and Advancements in Detection Methods. Microorganisms 2024; 12(7) doi: 10.3390/microorganisms12071482
|
| 191 |
Atahar Husein, Azfar Jamal, Mohammad Azhar Kamal, Yaser E. Alqurashi, Esam S. Al-Malki, Mohammed M. Naiyer, Syed Arif Hussain, Mohiuddin Khan Warsi. Hepatitis B virus–induced hepatocellular carcinoma: HBx-associated epigenetic mechanisms and therapeutic opportunities. Cancer Gene Therapy 2026; 33(5) doi: 10.1038/s41417-026-01051-6
|
| 192 |
Yexiang Du, Junhua Li, Jin Jiang, Guiqiong He, Wei Yu, Yehong Du. C1R suppresses hepatocellular carcinoma cell aggressiveness through promoting HIF-1α degradation and modulating cuproptosis-related protein expression. International Immunopharmacology 2026; 187 doi: 10.1016/j.intimp.2026.117248
|
| 193 |
Jian Xu, Yao Zhou, Ke Dong, Jun Gong, Wei Xiong, Xu Wang, Chun Gu, Xiang-yu Lu, De-pei Huang, Xu-dong Shen, Xue-ke She, Xiao-chen Zhao, Xiao-jiong Yu, Hao Zhang. Gene variation profile and its potential correlation with clinical characteristics in HBV-associated HCC patients of Sichuan Han nationality in China. Asian Journal of Surgery 2023; 46(10) doi: 10.1016/j.asjsur.2023.02.056
|
| 194 |
Héloïse Leroy, Mingyu Han, Marie Woottum, Lucie Bracq, Jérôme Bouchet, Maorong Xie, Serge Benichou. Virus-Mediated Cell-Cell Fusion. International Journal of Molecular Sciences 2020; 21(24) doi: 10.3390/ijms21249644
|
| 195 |
Haruyo Aoyagi, Hiroko Iijima, Eman S. Gaber, Takuma Zaitsu, Mami Matsuda, Kosho Wakae, Koichi Watashi, Ryosuke Suzuki, Takahiro Masaki, Jeffrey Kahn, Takeshi Saito, Mohamed El‐Kassas, Noritomo Shimada, Keizo Kato, Masaru Enomoto, Kazuhiko Hayashi, Akihito Tsubota, Ayako Mimata, Yuriko Sakamaki, Shizuko Ichinose, Masamichi Muramatsu, Kenjiro Wake, Takaji Wakita, Hideki Aizaki. Hepatocellular organellar abnormalities following elimination of hepatitis C virus. Liver International 2023; 43(8) doi: 10.1111/liv.15624
|
| 196 |
Lihong Shen, Lijia Shao, Shengchun Feng. Preoperative serum glutathione reductase activity and alpha-fetoprotein level are associated with early postoperative recurrence of hepatocellular carcinoma. Journal of Laboratory Medicine 2025; 49(1) doi: 10.1515/labmed-2024-0035
|
| 197 |
Jin Yang, Kai He, Mengyu Zhang, Lile Wu, Shu Qin, Ming Luo, Xianming Xia.
Unveiling the therapeutic potential of epigallocatechin gallate in liver cancer: insights from network pharmacology and
in vitro
assays
. Natural Product Research 2025; 39(23) doi: 10.1080/14786419.2024.2384083
|
| 198 |
Noha H. Habashy, Shaimaa A. Olleak, Marwa M. Abu-Serie, Nadia Z. Shaban. A new approach for the treatment of bleomycin-induced rat pulmonary injury by combined protein fraction of major royal jelly protein 2 and its isoform X1. Biomedicine & Pharmacotherapy 2023; 167 doi: 10.1016/j.biopha.2023.115578
|
| 199 |
LINGLI ZHANG, YAN LI, JINGXIN MAO. Research progress on natural products against hepatocellular carcinoma. BIOCELL 2024; 48(6) doi: 10.32604/biocell.2024.050396
|
| 200 |
Lanqian Su, Huanyu Luo, Yalan Yan, Zhongqiu Yang, Jiaan Lu, Danqi Xu, Linjuan Du, Jie Liu, Guanhu Yang, Hao Chi. Exploiting gender-based biomarkers and drug targets: advancing personalized therapeutic strategies in hepatocellular carcinoma. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1433540
|
| 201 |
Zhiyi Li, Ying Zhang, Baipan Zhang, Rui Guo, Minhua He, Zi-Ling Liu, Lei Yang, Hong Wang. Bibliometric study of immunotherapy for hepatocellular carcinoma. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1210802
|
| 202 |
Fatemeh Keikha, Zhi-Ping Liu. MTPrior: A Multi-Task Hierarchical Graph Embedding Framework for Prioritizing Hepatocellular Carcinoma-Associated Genes and Long Noncoding RNAs. IEEE Journal of Biomedical and Health Informatics 2026; 30(1) doi: 10.1109/JBHI.2025.3584342
|
| 203 |
Daria Apostolo, Luciana L. Ferreira, Federica Vincenzi, Nicole Vercellino, Rosalba Minisini, Federico Latini, Barbara Ferrari, Michela E. Burlone, Mario Pirisi, Mattia Bellan. From MASH to HCC: the role of Gas6/TAM receptors. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1332818
|
| 204 |
|
| 205 |
Hao Zhang. Quantitative PCR-based high-sensitivity detection of HBV-DNA levels reflects liver function deterioration in patients with hepatitis B virus-related cirrhosis. American Journal of Translational Research 2024; 16(6) doi: 10.62347/BDLO2786
|
| 206 |
Vaia Valiakou, Petros Eliadis, Eirini Karamichali, Ourania Tsitsilonis, John Koskinas, Urania Georgopoulou, Pelagia Foka. Differential Expression of the Host Lipid Regulators ANGPTL-3 and ANGPTL-4 in HCV Infection and Treatment. International Journal of Molecular Sciences 2021; 22(15) doi: 10.3390/ijms22157961
|
| 207 |
N. A. Vlasova, V. I. Apanasevich, E. V. Eliseeva, S. S. Startsev. Etiological, Epidemiological, and Medical-Economic Aspects of Hepatocellular Carcinoma (A Review). Cell and Tissue Biology 2025; 19(6) doi: 10.1134/S1990519X25060033
|
| 208 |
Elizabeth S. Borden, Annika Jorgensen, Heini M. Natri, Karen Taraszka Hastings, Kenneth H. Buetow, Melissa A. Wilson. HCV- and HBV-mediated liver cancer converge on similar transcriptomic landscapes and immune profiles. Human Genetics and Genomics Advances 2025; 6(1) doi: 10.1016/j.xhgg.2024.100373
|
| 209 |
Mara Klöhn, Jil Alexandra Schrader, Yannick Brüggemann, Daniel Todt, Eike Steinmann. Beyond the Usual Suspects: Hepatitis E Virus and Its Implications in Hepatocellular Carcinoma. Cancers 2021; 13(22) doi: 10.3390/cancers13225867
|
| 210 |
Nisha Sahu, Samrat Rakshit, L.V.K.S. Bhaskar. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma. 2022; doi: 10.1016/B978-0-323-98806-3.00023-4
|
| 211 |
Naoko Murata‐Kamiya, Masanori Hatakeyama. Helicobacter pylori‐induced DNA double‐stranded break in the development of gastric cancer. Cancer Science 2022; 113(6) doi: 10.1111/cas.15357
|
| 212 |
Xubo Huang, Joseph T. Glessner, Jinxia Huang, Desheng Zhou, Michael E. March, Hongna Wang, Qianghua Xia, Hakon Hakonarson, Jin Li. Discovery of Novel Host Molecular Factors Underlying HBV/HCV Infection. Frontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.690882
|
| 213 |
Alessandro Vitale, Gianluca Svegliati-Baroni, Alessio Ortolani, Monica Cucco, Giulio V Dalla Riva, Edoardo G Giannini, Fabio Piscaglia, Gianludovico Rapaccini, Mariella Di Marco, Eugenio Caturelli, Marco Zoli, Rodolfo Sacco, Giuseppe Cabibbo, Fabio Marra, Andrea Mega, Filomena Morisco, Antonio Gasbarrini, Francesco Giuseppe Foschi, Gabriele Missale, Alberto Masotto, Gerardo Nardone, Giovanni Raimondo, Francesco Azzaroli, Gianpaolo Vidili, Filippo Oliveri, Filippo Pelizzaro, Rafael Ramirez Morales, Umberto Cillo, Franco Trevisani, Luca Miele, Giulio Marchesini, Fabio Farinati. Epidemiological trends and trajectories of MAFLD-associated hepatocellular carcinoma 2002–2033: the ITA.LI.CA database. Gut 2023; 72(1) doi: 10.1136/gutjnl-2021-324915
|
| 214 |
Emine Karaca Sulukoğlu, Şükran Günaydın, Şeyda Nur Kalın, Ahmet Altay, Harun Budak. Diffractaic acid exerts anti-cancer effects on hepatocellular carcinoma HepG2 cells by inducing apoptosis and suppressing migration through targeting thioredoxin reductase 1. Naunyn-Schmiedeberg's Archives of Pharmacology 2024; 397(8) doi: 10.1007/s00210-024-02980-5
|
| 215 |
Janos Minarovits. Human tumor viruses: induction of three-dimensional alterations in the host genome structure. Frontiers in Microbiology 2023; 14 doi: 10.3389/fmicb.2023.1280210
|
| 216 |
Simmone D’souza, Layla Al-Yasiri, Annie Chen, Dan T. Boghici, Guido van Marle, Jennifer A. Corcoran, Trushar R. Patel, Carla S. Coffin. Development of Low-Cost In-House Assays for Quantitative Detection of HBsAg, HBeAg, and HBV DNA to Enhance Hepatitis B Virus Diagnostics and Antiviral Screening in Resource-Limited Settings. Pathogens 2025; 14(3) doi: 10.3390/pathogens14030258
|
| 217 |
E. A. Antropova, T. M. Khlebodarova, P. S. Demenkov, A. S. Venzel, N. V. Ivanisenko, A. D. Gavrilenko, T. V. Ivanisenko, A. V. Adamovskaya, P. M. Revva, I. N. Lavrik, V. A. Ivanisenko. Computer analysis of regulation of hepatocarcinoma marker genes hypermethylated by HCV proteins. Vavilov Journal of Genetics and Breeding 2023; 26(8) doi: 10.18699/VJGB-22-89
|
| 218 |
Junying Wang, Guangyu Zhu. Silencing of keratin 15 impairs viability and mobility while facilitating the doxorubicin chemosensitivity by inactivating the β‑catenin pathway in liver cancer. Oncology Letters 2023; 26(4) doi: 10.3892/ol.2023.14034
|
| 219 |
Chunye Zhang, Yuxiang Sui, Shuai Liu, Ming Yang. The Roles of Myeloid-Derived Suppressor Cells in Liver Disease. Biomedicines 2024; 12(2) doi: 10.3390/biomedicines12020299
|
| 220 |
Tianfeng Sun, Jing Zhang. ETV4 mediates the Wnt/β-catenin pathway through transcriptional activation of ANXA2 to promote hepatitis B virus-associated liver hepatocellular carcinoma progression. The Journal of Biochemistry 2021; 170(5) doi: 10.1093/jb/mvab088
|
| 221 |
Alkistis Papatheodoridi, George Papatheodoridis. Hepatocellular carcinoma: The virus or the liver?. Liver International 2023; 43(S1) doi: 10.1111/liv.15253
|
| 222 |
Aldona Kasprzak, Agnieszka Adamek. Role of the Ghrelin System in Colitis and Hepatitis as Risk Factors for Inflammatory-Related Cancers. International Journal of Molecular Sciences 2022; 23(19) doi: 10.3390/ijms231911188
|
| 223 |
Mirco Glitscher, Eberhard Hildt, Daniela Bender. Hepatitis B und C: Mechanismen der virusinduzierten Leberpathogenese und Tumorentstehung. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz 2022; 65(2) doi: 10.1007/s00103-021-03482-y
|
| 224 |
Luis E. Gomez-Quiroz, Sonia Roman. Influence of genetic and environmental risk factors in the development of hepatocellular carcinoma in Mexico. Annals of Hepatology 2022; 27 doi: 10.1016/j.aohep.2021.100649
|
| 225 |
Sihui Zhang, Guanqi Zhang, Chenxuan Zhang, Rongqiang Liu, Man Li, Xun Li, Jia Yu. Prognostic value of inflammation-immunity-nutrition score in patients with cancers. Discover Oncology 2026; 17(1) doi: 10.1007/s12672-026-05301-9
|
| 226 |
Israa Habeeb Naser. Association between Hepatitis B Viral Load and Liver Function Biomarkers in Patients with Chronic Hepatitis B. Academia Open 2026; 12(1) doi: 10.21070/acopen.12.2027.15325
|
| 227 |
Yating Xiao, Zhirui Tian, Jie Cui, Xia Yang, Dong Wang, Yangyang Cai, Qian Wu, Yaxin Jin, Hua Chen, Kai Ji. Natural Alkaloids Against Liver Injury: Mechanistic Insights and Multi-Target Therapeutic Potential. Biomolecules 2026; 16(6) doi: 10.3390/biom16060815
|
| 228 |
Jiaye Long, Kai Cui, Du Wang, Shuxin Qin, Zhong Li. Burden of Hepatocellular Carcinoma and Its Underlying Etiologies in China, 1990-2021: Findings From the Global Burden of Disease Study 2021. Cancer Control 2024; 31 doi: 10.1177/10732748241310573
|
| 229 |
Nisar Amin, Javaria Anwar, Abdullahi Sulaiman, Nadia Nikolaeva Naumova, Nadeem Anwar. Hepatocellular Carcinoma: A Comprehensive Review. Diseases 2025; 13(7) doi: 10.3390/diseases13070207
|
| 230 |
Jie Li, Mengdie Chen, Lusheng Wang, Kesheng Bo, Ming Chen, Hui Jiang. Camrelizumab-associated MG-like ocular neuromuscular toxicity after PD-1 inhibitor rechallenge in metastatic hepatocellular carcinoma: a case report with serial muscle injury-related biomarker changes. Frontiers in Immunology 2026; 17 doi: 10.3389/fimmu.2026.1908789
|
| 231 |
Yunzhao Hu, Chenchen Hao, Chengyuan Dong, Ping Tao, Jia Wang, Qun Lu. Identification of a novel ferroptosis-related gene signature in hepatocellular carcinoma: clinical significance, tumor microenvironment, drug sensitivity, and gene landscape analysis. Discover Oncology 2025; 16(1) doi: 10.1007/s12672-025-03123-9
|
| 232 |
Rui Qiang, Yanbo Li, Xincan Dai, Wenliang Lv. NLRP3 inflammasome in digestive diseases: From mechanism to therapy. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.978190
|
| 233 |
Qianni Zong, Chunying Liu, Hongwei Lv, Guishuai Lv, Liang Wang, Hongyang Wang, Wen Yang. Tertiary lymphoid structures and hepatocellular carcinoma: Guardian and executioner. Cancer Letters 2026; 657 doi: 10.1016/j.canlet.2026.218720
|
| 234 |
Yung-Fang Hsiao, Shao-Bin Cheng, Chia-Yu Lai, Hsiao-Tien Liu, Shih-Chien Huang, Yi-Chia Huang. The Prognostic Role of Glutathione and Its Related Antioxidant Enzymes in the Recurrence of Hepatocellular Carcinoma. Nutrients 2021; 13(11) doi: 10.3390/nu13114071
|